Elizabeth M. Klements, MS, PPCNP-BC, AE-C
Asthma Clinical Nurse Specialist
Boston Children's Hospital
Kenan Haver, MD
Director, Pulmonary Division Asthma Center
Associate Director, Boston Children's Hospital Asthma Center
Founding Member and Co-Director, Partners Asthma Center International
Assistant Professor of Pediatrics
Harvard Medical School
CME: 0.75 AMA PRA Category 1 CreditTM
NAPNAP CE: 0.75 contact hour (0.5 of which contains pharmacology content)
Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these patients over long periods of time. This activity will address the primary components of asthma management, including assessment of severity and control, tailored therapy, and patient education and counseling.
This activity is jointly provided by the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, and MCM Education.
This activity is designed for pediatricians, pediatric NPs, and other clinicians who manage asthma in pediatric patients.
Upon completion of this educational activity, the participant should be able to:
- Review options for the pharmacologic treatment of pediatric asthma.
- Develop an evidence-based approach to the pharmacologic management of pediatric asthma.
- Discuss optimal approaches to patient and caregiver asthma management education.
- Review tools for effective monitoring of asthma control.
Elizabeth M. Klements, MS, PPCNP-BC, AE-C, has nothing to disclose.
Kenan Haver, MD, has nothing to disclose.
Penn State faculty and staff involved in the development and review of this activity have nothing to disclose.
Lilian McVey, MD, medical writer, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Affairs, has nothing to disclose.
Terry Ann Glauser, MD, MPH, MCM Education VP, Medical Affairs, has nothing to disclose.
It is the policy of the National Association of Pediatric Nurse Practitioners and Penn State College of Medicine to ensure balance, independence, objectivity and scientific rigor in all of their educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing clinician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
This program is accredited for 0.75 NAPNAP CE contact hours (0.5 of which contains pharmacology content) per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 80% or better on the post-test.
The online activity will take approximately 45 minutes to complete.
For questions regarding CME credit, contact Penn State Continuing Education at (717) 531-6483 or ContinuingEd@hmc.psu.edu. Please reference activity code G6019-17-T.
Commercial Support Statements
Supported by independent educational grants from Genentech and Novartis.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
- Please turn off all pop-up blockers to allow access to the educational activity.
- Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
- The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 45 minutes to complete.
- After you have finished reviewing the activity, click on the "Post-test" button.
- Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
©2016, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, Genentech, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.